Triple-negative breast cancer live more than ten years not many, the current triple-negative breast cancer treatment means less, higher degree of malignancy and easy to metastasize, often poor prognosis, according to the World Health Organization’s International Agency for Research on Cancer (IARC) and the Lancet (lancet) journal 2021 reported that triple-negative breast cancer 5-year survival rate is only about 11%. 1. Fewer treatment options. Triple-negative breast cancer means that immunohistochemistry is negative for Her-2, estrogen receptor and progesterone receptor, so it is impossible to accept molecular targeted therapy and endocrine therapy, and the only treatment means that can be taken are chemotherapy and local radiotherapy. 2. High degree of tumor malignancy and rapid metastasis. Tumor cells of patients with triple-negative breast cancer are usually low-differentiated, with high malignancy, and because of the lack of treatment means, patients’ tumors metastasize rapidly, so the prognosis is very poor, with a five-year survival rate of only 11%, and a ten-year survival rate of patients is very low. However, with early detection and early treatment, it is still possible to live beyond ten years. It is recommended that patients suffering from triple-negative breast cancer should consult hospitals in time, actively receive regular treatment, and at the same time regulate their emotions to improve their quality of life and strive for a longer survival period.